Search

everythinglearnresearchcommunity

for

Search:↓

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

About 15% of US Army personnel use hair products containing hormone or placenta, with higher usage among non-whites, females, and enlisted personnel.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

Adrenarche increases adrenal androgens around age 6, affecting hair growth and development.

The white wax scale insect's genome shows that complete metamorphosis evolved earlier than thought and highlights differences in male and female development.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Ginger and cinnamon can help manage PCOS and related disorders by reducing oxidative stress and inflammation.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.